Background And Objectives: Proximal advanced gastric cancer that invades the greater curvature is often treated by prophylactic splenectomy because of a risk for metastasis to the splenic hilar lymph node (station No.10). We evaluated whether laparoscopic spleen-preserving splenic hilar dissection (SPSHD) could be a better approach.

Methods: We reviewed records of patients with proximal gastric cancer who underwent total gastrectomy with No.10 dissection between 2012 and 2018 using our in-house database set. We divided patients by whether they had received SPSHD or splenectomy, first to compare surgical outcomes, and subsequently to analyze survival outcomes among patients with tumors invading the greater curvature.

Results: Of 145 patients enrolled in this study, 82 had SPSHDs and 63 had splenectomies. All SPSHDs were laparoscopic; 80% of splenectomies were laparotomic. Morbidity ≥ grade III was seen in 8.5% of the SPSHD group and 11.1% of the splenectomy group. The median number of retrieved No. 10 nodes was three in each group. In multivariable analysis, SPSHD was not an independent prognostic factor among patients whose tumors invaded the greater curvature (n = 73). Among propensity-matched cohorts (n = 25 each), 5-year relapse-free survival rates were 77.6% in the SPSHD group and 49.9% in the splenectomy group.

Conclusion: Laparoscopic SPSHD can potentially replace prophylactic splenectomy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2020.11.133DOI Listing

Publication Analysis

Top Keywords

splenic hilar
12
prophylactic splenectomy
12
laparoscopic spleen-preserving
8
spleen-preserving splenic
8
hilar lymph
8
lymph node
8
replace prophylactic
8
proximal advanced
8
advanced gastric
8
gastric cancer
8

Similar Publications

Background: Autoimmune hepatitis (AIH) is a chronic liver inflammatory disease mediated by autoimmune reactions, the pathogenesis of AIH is probably related to the imbalance of intestinal flora. Yinchenhao decoction (YCHD) has been used to relieve AIH. However, the mechanisms underpinning YCHD's hepatoprotective effects with the gut microbito have not been fully revealed.

View Article and Find Full Text PDF

Lymphadenectomy (LND) is a crucial component of the curative surgical treatment of gastric cancer (GC). The LND serves to both accurately stage the disease and offer therapeutic benefits. At the time of "curative-intent" gastrectomy, D2 LND is the optimal treatment for patients with locally advanced GC due to its survival benefits and acceptable morbidity.

View Article and Find Full Text PDF
Article Synopsis
  • Total gastrectomy with splenic hilar nodal dissection is a common procedure for treating resectable scirrhous gastric cancer (GC), but the necessity of splenectomy specifically for antral-type GC is uncertain.
  • A study at the National Cancer Center Hospital analyzed patients with type IV GC from 2000 to 2018, focusing on those who underwent total gastrectomy with splenectomy and achieved successful tumor resections.
  • Results showed no metastasis to the splenic hilar nodes in patients with antral-type GC, suggesting that splenectomy may not be needed for this subtype, while it was common in body-type GC cases.
View Article and Find Full Text PDF

Background: This study aims to investigate the feasibility and value of modular splenic hilar lymphadenectomy (MSHL) in LTG for advanced PGC located at the greater curvature.

Study Design: A retrospective-controlled research included 54 patients diagnosed with advanced PGC located at the greater curvature who underwent LTG combined with spleen-preserving hilar lymphadenectomy between January 2020 and December 2022 at the same treatment center. A total of 20 patients underwent classic splenic hilar lymphadenectomy (CSHL) using a medial approach (classic group), while 34 patients underwent MSHL (modular group).

View Article and Find Full Text PDF

Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study.

Am J Case Rep

August 2024

Department of Pathology and Laboratory Medicine, Zucker School of Medicine, North Shore University Hospital/Long Island Jewish Medical Center, Northwell Health, Greenvale, NY, USA.

Article Synopsis
  • Cervical cancer is the fourth most common cancer in women, with squamous cell carcinoma making up 70% of cases, often spreading to areas like the lungs and lymph nodes.
  • A case of a 42-year-old woman previously treated for advanced cervical cancer is reported, where she presented with symptoms and was found to have malignant cells in her pericardial fluid, indicating rare metastasis to the pericardium.
  • The case highlights the importance of considering cervical cancer as a potential source of pericardial effusion, especially in patients with invasive tumors or known cancer history.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!